Intestinal Regeneration
Natural health product licensed in Canada
- Licence holder
- CF Silver, LLC
- NPN or DIN-HM
- 80069581
- Status
- Active licence
- Licence date
- 19 May 2016
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Althaea officinalis Source : Racine | 7.5 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - fruit | 7.875 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine | 7.5 mg | Not calculated |
| Cyamopsis tetragonoloba Source : Seed endosperm | 11.25 mg | Not calculated |
| Cinnamomum verum Source : Écorce (branche) | 7.5 mg | Not calculated |
| Rubus idaeus Source : Fruit | 7.5 mg | Not calculated |
| Maltodextrine Source : Maltodextrin | 650 mg | Not calculated |
| Mentha x piperita Source : Feuille | 7.5 mg | Not calculated |
| Plantago ovata Source : Enveloppe | 7,500 mg | Not calculated |
| Fructooligosaccharides Source : Cichorium intybus - racine | 500 mg | Not calculated |
| Aloe vera Source : Gel de la feuille | 30 mg | Not calculated |
| Ulmus rubra Source : Stem bark - inner | 11.25 mg | Not calculated |
| Medicago sativa Source : Sommité | 7.875 mg | Not calculated |
| Agathosma betulina Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 31.5 mg | 7.875 mg | Not calculated |
| Arctium lappa Source : Racine | 7.875 mg | Not calculated |
| Capsicum annuum Source : Fruit | 15 mg | Not calculated |
| Stellaria media Source : Feuille | 7.5 mg | Not calculated |
| Zea mays Source : Stigmates | 7.5 mg | Not calculated |
| Taraxacum officinale Source : Feuille | 7.5 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) | 7.5 mg | Not calculated |
| Allium sativum Source : Bulbe | 7.5 mg | Not calculated |
| Zingiber officinale Source : Racine | 7.5 mg | Not calculated |
| Carica papaya Source : Fruit | 7.5 mg | Not calculated |
| Cucurbita pepo Source : Graine(s) | 7.5 mg | Not calculated |
| Rheum undulatum Source : Racine | 7.5 mg | Not calculated |
| Yucca filamentosa Source : Racine | 7.5 mg | Not calculated |
| Syzygium aromaticum Source : Bourgeon floral | 3.75 mg | Not calculated |
| Gelidium amansii Source : En entier | 750 mg | Not calculated |
| Protéine de graines de chanvre Source : Cannabis sativa - Graine | 450 mg | Not calculated |
| Echinacea angustifolia Source : Racine | 7.5 mg | Not calculated |
Non-medicinal ingredients
Silice, Feuille de Stevia rebaudiana, Stéarate de magnésium, Saveur, Extrait de fruit de monk
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 1 day |
Uses authorised in Canada
Bulk-forming laxative. Promotes bowel movements by increasing bulk volume and water content. Provides gentle relief of constipation and/or irregularity. Provides antioxidants that helps protect cells from oxidative damage caused by free radicals. Cayenne is traditionally used in Herbal Medicine to aid digestion. Cayenne is traditionally used in Herbal Medicine to help support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defecate following the use of another laxative product. Do not use if you have diabetes mellitus in which blood sugar is difficult to regulate. Do not use if you have difficulty swallowing. Do not use if you are pregnant or breastfeeding. Do not use if you have a history of systemic lupus erythematosus. Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder.
- Précautions et mises en garde
Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within seven days. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Consult a health care practitioner prior to use if you are taking medications which inhibit peristaltic movement (e.g. opioids, loperamide). Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, mega colon, faecal impaction, inflamed bowel or appendicitis). Consult a health care practitioner prior to use if you are taking blood thinners or protease inhibitors. Consult a health care practitioner prior to use if you are undergoing hormone replacement therapy (HRT) or taking birth control medication. Consult a health care practitioner prior to use if you have diabetes. Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If you have stomach ulcers or inflammation, consult a health care practitioner prior to use. If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a liver disorder. Consult a healthcare practitioner if symptoms persist or worsen. If you are taking immunosuppressants, consult a health care practitioner prior to use. If you have an autoimmune disorder, consult a health care practitioner prior to use. If you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have anaemia. Consult a health care practitioner prior to use if you have gallstones.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur following inhaled and/or ingested psyllium; in which case, discontinue use. May cause temporary gas and/or bloating. Hypersensitivity to fructooligosaccharides, burdock and garlic has been known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80069581
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.